Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Stock data | 2023 | Change |
---|---|---|
Price | $0.8749101228691961 | N/A |
Market Cap | $538.61M | N/A |
Shares Outstanding | 615.61M | -2.35% |
Employees | 10.50K | N/A |
Shareholder Equity | 1.51B | -21.62% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -1.46 | N/A |
P/S Ratio | 0.50 | N/A |
P/B Ratio | 0.36 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.1554 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $1.09B | N/A |
Earnings | -$234.03M | N/A |
EPS | -0.5975 | N/A |
Earnings Yield | -0.6829 | N/A |
Gross Margin | 0.8689 | N/A |
Operating Margin | 0.0575 | N/A |
Net income margin | -0.2155 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $2.32B | N/A |
Total Debt | $1.12B | N/A |
Cash on Hand | $73.37M | N/A |
Debt to Equity | 0.9070 | 23.65% |
Cash to Debt | 0.0653 | 42.86% |
Current Ratio | 0.5469 | -5.68% |